Patents by Inventor Roberta Avallone

Roberta Avallone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic use of P75 receptor antagonists
    Patent number: 9763940
    Abstract: The present disclosure relates to the use of a (heterocycle-fused piperidine)-(piperazinyl)-1-alkanone derivative or (heterocycle-fused pyrrolidine)-(piperazinyl)-1-alkanone derivative or a pharmaceutically acceptable salt thereof as a p75 receptor antagonist in the treatment and/or prevention of overactive bladder.
    Type: Grant
    Filed: August 10, 2016
    Date of Patent: September 19, 2017
    Assignee: SANOFI
    Inventors: Roberta Avallone, Marco Baroni, Tiziano Croci
  • NOVEL THERAPEUTIC USE OF P75 RECEPTOR ANTAGONISTS
    Publication number: 20170056400
    Abstract: The present disclosure relates to the use of a p75 receptor antagonist or its pharmaceutically acceptable salts for the preparation of a medicament for use in the treatment and/or prevention of overactive bladder.
    Type: Application
    Filed: August 10, 2016
    Publication date: March 2, 2017
    Inventors: Roberta AVALLONE, Marco BARONI, Tiziano CROCI
  • NOVEL THERAPEUTIC USE OF P75 RECEPTOR ANTAGONISTS
    Publication number: 20140296513
    Abstract: The present disclosure relates to the use of a p75 receptor antagonist or its pharmaceutically acceptable salts for the preparation of a medicament for use in the treatment and/or prevention of overactive bladder.
    Type: Application
    Filed: June 17, 2014
    Publication date: October 2, 2014
    Inventors: Roberta AVALLONE, Marco BARONI, Tiziano CROCI
  • Use of a Cannabinoid CB1 Receptor Antagonist for Preparation of Drugs Useful for the Prevention and Treatment of Benign Prostatic Hypertrophy
    Publication number: 20090124643
    Abstract: The present invention relates to the use of cannabinoid CB1 receptor antagonist for the preparation of drugs useful for the prevention and treatment of benign prostatic hypertrophy.
    Type: Application
    Filed: December 3, 2008
    Publication date: May 14, 2009
    Applicant: SANOFI-AVENTIS
    Inventors: Tiziano Croci, Fabio Guagnini, Roberta Avallone